Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03691714 · COMPLETED

Trial details

NCT number: NCT03691714
Sponsor: Trisha Wise-Draper
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Head and Neck Cancer Head and Neck Neoplasms Metastatic Cancer

Start date: 2018-10-23
Primary completion: 2024-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.